Bronchodilator
Pregnancy: C — safe at inhaled doses; tocolytic at high IV doses
Salbutamol (Albuterol)
Brand names: Ventolin, Salamol, Bricanyl
Adult dose
Dose: Inhaled MDI: 100–200mcg (1–2 puffs) PRN. Nebulised: 2.5–5mg. IV infusion: 3–20 mcg/min
Route: Inhaled / Nebulised / IV
Frequency: PRN (inhaler) or continuous (nebuliser in acute asthma)
Acute severe asthma: 5mg nebulised every 20–30 min or back-to-back. Life-threatening asthma: IV infusion 5–20 mcg/min. Hyperkalaemia: 10–20mg nebulised (4 vials back-to-back).
Paediatric dose
Route: Nebulised (acute asthma) / Inhaled MDI + spacer (mild–moderate)
Frequency: Every 20–30 min × 3, then reassess (acute severe)
Max: 5 mg per nebulised dose
Concentration: 5 mg/ml
Age bands
- 1–60m: Nebulised 2.5 mg every 20–30 min in acute severe asthma
- 60–216m: Nebulised 5 mg every 20–30 min in acute severe asthma
BNFc / BTS-SIGN paediatric asthma: nebulised 2.5 mg (child 1 month–4 years) or 5 mg (child 5–17 years) every 20–30 min in acute severe asthma; back-to-back if life-threatening. MDI + spacer (mild–moderate): up to 10 puffs (100 microgram each), one puff at a time, every 30–60 sec, repeated every 20 min. IV salbutamol (specialist, severe): 15 micrograms/kg single bolus over 5 min, then 1–5 micrograms/kg/min infusion — distinct dosing.
Clinical pearls
- Hyperkalaemia: high-dose nebulised salbutamol (10–20mg) shifts K+ into cells — onset 30 min, reduces K+ by ~1 mmol/L. NOT a definitive treatment.
- Spacer device = as effective as nebuliser for acute asthma in children and adults. Use MDI + spacer if nebuliser not available.
- Inhaler technique: press inhaler, then inhale slowly over 4–5 sec, hold 10 sec — ensures lung deposition.
- Monitor K+ in severe acute asthma — nebulised salbutamol causes hypokalaemia; exacerbated by concomitant theophylline.
Contraindications
- Hypersensitivity to salbutamol
- Tachyarrhythmia as sole indication (relative)
- Threatened abortion (IV route)
Side effects
- Tachycardia, palpitations (dose-dependent)
- Fine tremor (common with nebulised/IV)
- Hypokalaemia (particularly at high nebulised doses — monitor K+ in severe asthma)
- Hyperglycaemia
- Paradoxical bronchospasm (rare)
Interactions
- Non-selective beta-blockers (propranolol): antagonise bronchodilation — avoid in asthma
- Theophylline: additive hypokalaemia risk
- Loop diuretics: additive hypokalaemia
- Digoxin: salbutamol-induced hypokalaemia increases digoxin toxicity risk
Monitoring
- Peak flow / FEV₁
- HR
- K+ in severe asthma
- SpO₂
Reference: BNFc; BTS/SIGN Asthma 2023; NICE BNF 84. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
Pathways
- Acute Asthma in Adults · BTS/SIGN British Guideline on Asthma 2019; NICE NG80
- Pulmonary Embolism Assessment · NICE NG158; ESC 2019 PE Guidelines
- Acute Exacerbation of COPD (AECOPD) · NICE NG115; GOLD 2024
- Spontaneous Pneumothorax (Adult) · BTS Pleural Disease 2023
- Atypical Pneumonia (Legionella / Mycoplasma / Chlamydophila) · BTS 2023; IDSA
- COPD Exacerbation Management · NICE NG115 / GOLD 2024